• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Stocks

Is It Time to Clean Out Consumer Staples Stocks From Your Portfolio?

Investors are understandably reassessing these pandemic-driven names.
By KEVIN CURRAN Feb 08, 2022 | 10:30 AM EST
Stocks quotes in this article: CLX, PG, KMB, UL, CHD

Not too long ago, stocks such as Clorox (CLX) , Procter & Gamble (PG) , and Kimberly-Clark (KMB) found themselves as unlikely market darlings. Fear about the burgeoning coronavirus in early 2020 led to scenes of mad scrambles for cleaning products, toilet paper, and more with each of these names scrambling to stock shelves.

While the scenes were chaotic for shoppers, they were helpful to shareholders who saw shares boosted to all-time highs on the soaring demand. However, the trajectory since has been less than encouraging and, after an abysmal earnings release from Clorox last week, investors are understandably reassessing these pandemic-driven staples stocks.

Clorox Clean-Out

To be fair to the trend, it would be hard to imagine demand for products like those from Clorox ever reaching quite the heights that the 2020 zenith saw in many of these names. However, few expected quite the sudden retraction seen by Clorox in last week's earnings release.

The company reported a decline on both the top and bottom lines and tempered guidance, touting higher costs and lessened demand.

"We faced significant cost headwinds in a volatile operating environment in Q2," CEO Linda Rendle acknowledged. "We anticipate this highly dynamic and challenging environment to persist over the near term and [we] adjusted our fiscal 2022 outlook as a result."

While she remained confident in brand superiority and persistent demand to carry the company through the headwinds, analysts were not as convinced.

The results motivated Atlantic Equities and Morgan Stanley to downgrade the stock to "Underweight" and trim price targets, while previously bearish firms like J.P. Morgan and Barclays reiterated their negative outlook for the stock despite the optimistic comments from management.

Amid the commotion, the stock slumped about 15% into the end of the week, dragging down many of its peers along the way given the macro commentary.

To be sure, some analysts were not ready to abandon the name.

"Although we are taking our medicine now, we think the stock is a Buy at these levels," Citi analyst Wendy Nicholson wrote in a note to clients.

Still, even she cut her price target to $160 from an ambitious $194, advising clients to temper expectations even amidst the opportunity she encouraged.

Inflation vs. Omicron

The opportunity may well be available yet, given the persistent fears of variants that emerge over time. At present, no name has taken hold of the market to quite the degree as Omicron, the newer and more virulent strain of coronavirus that cropped up at the close of 2021.

According to the Environmental protection Agency, products like Clorox are useful in preventing spread on surfaces and therefore critical to prevention. As such, if case numbers continue to carry upward, the demand that made Clorox such a critical beneficiary of early Covid spikes could certainly resurface.

The equation for Clorox moving forward is one that not only incorporates demand, however. It also must account for inflationary concerns that are putting major pressure on the firm. The problem that provoked such a slide in the presumably "safe stock" was fueled by pinched margins that prompted such a glaring miss on profitability.

"I do think that's going to take some time given the level of inflation we're dealing with and I think you're hearing from us and a lot of peers," Clorox CFO Kevin Jacobsen told analysts on the firm's earnings call. "This is a unique environment with an extreme level of cost inflation."

Per the earnings release, gross margins were cut by over 12%.

Clearly, these inflationary concerns and supply-chain issues that are shrinking margins are not unique to Clorox either. As such, Kleenex-maker Kimberly-Clark has seen its share price cut nearly 10% in the past week, while Anglo-Dutch leader Unilever (UL) has slid strongly as these headwinds add to its own host of issues. Additionally, both Church & Dwight (CHD) and Procter & Gamble have taken comparably mild hits in their own right.

Managing Margins

In the end, it is this comparative impact that is pertinent for investors, as stock-picking appears a paramount issue in the fallout from Covid and Omicron impacts.

For example, the comparatively mild hits to names such as Church & Dwight and Procter & Gamble pale in comparison to steady gains from the dividend-driven stocks in the past year. In fact, in stark contrast to Clorox, both Procter and Church & Dwight shares have soared nearly 25% in the past year, cruising past even their early-Covid highs.

This resilience seems fueled overwhelmingly by an ability to apparently overcome inflation and maintain demand dynamics despite market headwinds.

"I think we're better positioned for dealing with an inflationary environment or revenue management in that sense than we've ever been before," Procter & Gamble CFO Andre Schulten told analysts in late January. "Starting with a portfolio that is focused on daily use categories health, hygiene and cleaning that are essential to the consumer versus discretionary categories, which in these environments are the first ones to lose focus from the consumer."

Similarly, Church & Dwight noted that it will take action to raise prices on 80% of its brands this month, with eyes on additional maneuvers. As the company managed to beat on earnings and maintain demand in its most recently published results, its pricing power appears able to withstand and overcome pressure on margins.

These commentaries come in direct contrast to results from Clorox, suggesting that the execution amid this pressure is the key issue. Additionally, it highlights for investors the idea that inflation, not Omicron, is the important headwind for companies to get a handle on at the moment.

Stock-pickers, therefore, must select accordingly.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Curran was long PG.

TAGS: Dividends | Earnings | Fundamental Analysis | Investing | Stocks | Value Investing | Consumer Staples | Analyst Actions | U.S. Equity | Coronavirus

More from Stocks

Even Some Out of Fashion Names Are Now Back in Style

Jonathan Heller
Jan 27, 2023 12:30 PM EST

Sure, we're only one month in to 2023, but so far these stocks are starting the new year with a bang.

I'm Making Small Bets With These 2 Stocks

Bret Jensen
Jan 27, 2023 11:30 AM EST

While I remain cautious on the overall market, I continue to act upon the limited opportunities I'm finding in the current market.

Chevron Is Crushing It and for My Portfolio Too: Here's the Trade

Stephen Guilfoyle
Jan 27, 2023 10:51 AM EST

The only reason to exit the stock now is profit-taking.

Adani Companies Plunge Under Hindenburg Attack, Hurting Secondary Sale Attempt

Alex Frew McMillan
Jan 27, 2023 9:30 AM EST

Retail investors may baulk now they are being offered Adani Enterprises shares at a range well above their current trading price.

Intel Tanks (Again), but I Spy 3 Other Charts That Look Pretty Darn Good

Bob Byrne
Jan 27, 2023 9:00 AM EST

The trio consists of a beverage seller, a connectivity company and a producer of advanced driving system technology.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:48 AM EST REAL MONEY

    Watch Doug Kass on the Daily Rundown!

    In today's Action Alerts PLUS Daily Rundown, Doug ...
  • 11:03 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend On Real Money

    It's time to start using this power to build great...
  • 03:06 PM EST BOB LANG

    LEAPS Webinar

    This week, I offered a free webinar session talkin...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login